Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!
Top 5 Fast-growings companies in Insulin pen by Most Patent Filing In 1 Year in the China in 2022
The Insulin pen top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filing In 1 Year Insulin pen Fast-growings in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
An insulin pen is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. It was introduced and marketed as NovoPen by the Danish company Novo Nordisk in 1985.